A
AC Immune SA (ACIU)
NGM – Real Time Price. Currency in USD
2.77
-0.06 (-2.12%)
At close: May 12, 2026, 4:00 PM EDT
2.82
+0.05 (1.77%)
Pre-market: May 13, 2026, 4:12 AM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
2.77
-0.06 (-2.12%)
At close: May 12, 2026, 4:00 PM EDT
2.82
+0.05 (1.77%)
Pre-market: May 13, 2026, 4:12 AM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.87 | 6.05 | 5.0 | |
| Quick ratio | N/A | 5.63 | 1.0 | |
| Debt to Equity | 0.14 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | -227.68 | -16.91 | 1.0 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 16M | 31M | 4M | 5M |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | -76M | -61M | -60M | -83M | -80M |
| Net Income | -74M | -60M | -58M | -85M | -82M |
| EBITDA | -73M | -59M | -57M | -80M | -59M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 2755.94 | 196.59 | 10 |
| Next quarter | -65.13 | -23.84 | 1.0 |
| Current year | 787.25 | 50.87 | 10 |
| Next year | 189.71 | 159.99 | 10 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 237.64 | -5.01 | -6.27 | 14.48 | 5.0 |
| Y/Y | 29.66 | 10.77 | 12.55 | -459.56 | 6.5 |
| 3y average | 100.64 | -7.98 | -5.56 | 2.62 | 4.0 |
| 5y average | 240.18 | -7.55 | -2.29 | -2.29 | 3.3 |
| Weighted average score | 4.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $23.9M significantly exceed its total debt $5.4M, ensuring strong financial flexibility
Total current liabilities $114.8M surpass Total current assets $99.6M, signaling liquidity issues
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-227.7x) is dangerously low, suggesting debt repayment risks